flâneur

CSL's blood payments in US come under the microscope

smh.com.au · 1,141 words · saved by 1 readers

Australian Ethical is asking the biotech giant to clarify how it will manage the risks posed by people in the US making donations more frequently to supplement their income.

CSL's blood payments in US come under the microscope Advertisement CSL has been forced to defend the way it runs its blood plasma collection business in the US amid concerns the company will face increased scrutiny over how it handles the health and welfare of blood donors. Wealth manager Australian Ethical, which has $3.8 billion under management, is seeking clarity from the ASX- listed biotech giant on how it will manage the level and frequency of donation payments, at a time when unemployment is ramping up in the US. Plasma collection is a "moral maze" and the ethics are about to be front a

related reading